A combined panel of Eotaxin-1, SAA, IL-6, and IL-8 showed the best prediction of the actual mucosal status in IBD with a sensitivity of 90.7% and specificity of 68.4%. The gene discussed is CXCL8; the disease is irritable bowel syndrome.